GeNeuro SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GeNeuro SA
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
/ 
Others were interested in
Frequently asked questions
To buy GeNeuro SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for GeNeuro SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for GeNeuro SA is GNRO:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
GeNeuro SA has its primary listing on Euronext Paris. You can trade GeNeuro SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, GeNeuro SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include GeNeuro SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like GeNeuro SA.